Yan Y, Xu H, Zhao Y, Lin S, Zheng Y. Ticagrelor versus clopidogrel in patients with left main coronary artery stenting. Cardiovasc Drugs Ther. 2024. https://doi.org/10.1007/s10557-024-07636-3.

Article  PubMed  Google Scholar 

Wallentin L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–57. https://doi.org/10.1056/NEJMoa0904327.

Article  CAS  PubMed  Google Scholar 

Wang HY, Li Y, Xu XM, Li J, Han YL. Impact of baseline bleeding risk on efficacy and safety of ticagrelor versus clopidogrel in Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. Chin Med J (Engl). 2018;131(17):2017–24. https://doi.org/10.4103/0366-6999.239306.

Article  CAS  PubMed  Google Scholar 

Ko D, Evans PT, Lin KJ, et al. Frailty and clinical outcomes of ticagrelor versus clopidogrel in older adults with acute myocardial infarction. J Am Heart Assoc. 2024;13(15):e034529. https://doi.org/10.1161/JAHA.124.034529.

Article  PubMed  Google Scholar 

Huang HM, Ran FY, Chen J, et al. Outcomes of ticagrelor versus high-dose clopidogrel in CYP2C19 intermediate metabolizer undergoing percutaneous coronary intervention for acute coronary syndromes. J Cardiovasc Pharmacol. 2024;84(3):347–55. https://doi.org/10.1097/FJC.0000000000001582.

Article  CAS  PubMed  Google Scholar 

Triska J, Maitra N, Deshotels MR, et al. A comprehensive review of the pleiotropic effects of ticagrelor. Cardiovasc Drugs Ther. 2024;38(4):775–97. https://doi.org/10.1007/s10557-022-07373-5.

Article  CAS  PubMed  Google Scholar